Patents Assigned to Phoenix Biotechnology, Inc.
  • Method and compositions for treating Coronavirus infection
    Patent number: 11806359
    Abstract: A method of treating viral infection, such as viral infection caused by a virus of the Coronaviridae family, is provided. A composition having at least oleandrin or digoxin is used to treat the viral infection or the disease state of said viral infection.
    Type: Grant
    Filed: December 17, 2021
    Date of Patent: November 7, 2023
    Assignee: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Robert A. Newman, Otis C. Addington, Jose R. Matos, Richard J. Obiso
  • Extract containing oleandrin and method of production thereof
    Publication number: 20230158093
    Abstract: A subcritical liquid extraction process for the production of oleandrin or oleandrin-containing extract is provided. The process provides improvements over other methods of preparing oleandrin-containing extract. The extract, pharmaceutical compositions, dosage forms and nutraceutical compositions comprising oleandrin or said extract are provided. Methods of treating diseases, disorders or conditions that are therapeutically responsive to oleandrin are also provided.
    Type: Application
    Filed: November 23, 2022
    Publication date: May 25, 2023
    Applicant: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: ROBERT A. NEWMAN, OTIS C. ADDINGTON, RICHARD J. OBISO
  • Method and Compositions for Treating Glioblastoma
    Publication number: 20220362275
    Abstract: A method of treating glioma is provided. A combination protocol as described herein includes radiotherapy, chemotherapy, and pharmacotherapy. Resection of the glioma is optionally included in the combination protocol. Pharmacotherapy is conducted with an oleandrin-containing composition. Treatment of glioblastoma is particularly contemplated.
    Type: Application
    Filed: June 2, 2022
    Publication date: November 17, 2022
    Applicant: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: ROBERT A. NEWMAN, OTIS C. ADDINGTON, PEIYING YANG, CLAUDIO FESTUCCIA, JOSE R MATOS
  • Method and Compositions for Treating Coronavirus Infection
    Publication number: 20220160741
    Abstract: A method of treating viral infection, such as viral infection caused by a virus of the Coronaviridae family, is provided. A composition having at least oleandrin or digoxin is used to treat the viral infection or the disease state of said viral infection.
    Type: Application
    Filed: December 17, 2021
    Publication date: May 26, 2022
    Applicant: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Robert A. NEWMAN, Otis C. ADDINGTON, Jose R. Matos, RICHARD J. OBISO
  • Method of and improved composition for treating triterpene-responsive conditions, diseases or disorders
    Patent number: 11331291
    Abstract: A method of treating a triterpene-responsive condition, disease or disorder in a subject by administration of an improved triterpene-based composition is provided. An improved triterpene-based composition comprising at least two or at least three triterpenes present at a molar ratio as described herein is also provided.
    Type: Grant
    Filed: March 8, 2021
    Date of Patent: May 17, 2022
    Assignee: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Robert A. Newman, Otis C. Addington, Donald C. Lo, Linda S. Kaltenbach, Peiying Yang
  • Method and compositions for treating equine encephalitis
    Patent number: 11324789
    Abstract: A method of treating equine encephalitis is provided. A composition having at least one cardiac glycoside, such as oleandrin, is used to treat a viral infection causing the encephalitis. The composition can further include at least one triterpene. Alternatively, the composition comprises at least one, at least two, or at least three triterpenes.
    Type: Grant
    Filed: August 18, 2021
    Date of Patent: May 10, 2022
    Assignee: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Robert A. Newman, Otis C. Addington
  • Method and Compositions for Treating Coronavirus Infection
    Publication number: 20220054521
    Abstract: A method of treating viral infection, such as viral infection caused by a virus of the Coronaviridae family, is provided. A composition having at least oleandrin is used to treat viral infection.
    Type: Application
    Filed: September 13, 2021
    Publication date: February 24, 2022
    Applicant: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Robert A. NEWMAN, Otis C. ADDINGTON, Jose R. MATOS
  • Method and Compositions for Treating HTLV-1 Virus Infection
    Publication number: 20220047616
    Abstract: A method of treating HTLV-1 virus infection. A composition having at least one cardiac glycoside is used to treat viral infection. The composition can further include at least one triterpene. Alternatively, the composition comprises the combination of at least one cardiac glycoside and at least one, at least two, or at least three triterpenes.
    Type: Application
    Filed: October 27, 2021
    Publication date: February 17, 2022
    Applicant: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Robert A. NEWMAN, Otis C. ADDINGTON
  • Method and Compositions for Treating Equine Encephalitis
    Publication number: 20220031784
    Abstract: A method of treating equine encephalitis is provided. A composition having at least one cardiac glycoside, such as oleandrin, is used to treat a viral infection causing the encephalitis. The composition can further include at least one triterpene. Alternatively, the composition comprises at least one, at least two, or at least three triterpenes.
    Type: Application
    Filed: August 18, 2021
    Publication date: February 3, 2022
    Applicant: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Robert A. NEWMAN, Otis C. ADDINGTON
  • Method and compositions for treating viral infection
    Patent number: 11123387
    Abstract: A method of treating viral infection, such as viral infection caused by a virus of the Filoviridae family, Flaviviridae family (Flavivirus genus), Deltaretrovirus genus, or Togaviriade family is provided. A composition having at least one cardiac glycoside is used to treat viral infection. The composition can further include at least one triterpene. Alternatively, the composition comprises at least one, at least two, or at least three triterpenes.
    Type: Grant
    Filed: February 27, 2020
    Date of Patent: September 21, 2021
    Assignee: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Robert A. Newman, Otis C. Addington
  • Method of and Improved Composition for Treating Triterpene-Responsive Conditions, Diseases or Disorders
    Publication number: 20210267920
    Abstract: A method of treating a triterpene-responsive condition, disease or disorder in a subject by administration of an improved triterpene-based composition is provided. An improved triterpene-based composition comprising at least two or at least three triterpenes present at a molar ratio as described herein is also provided.
    Type: Application
    Filed: March 8, 2021
    Publication date: September 2, 2021
    Applicant: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: ROBERT A. NEWMAN, OTIS C. ADDINGTON, DONALD C. LO, LINDA S. KALTENBACH, PEIYING YANG
  • Method and compositions for treating viral infection
    Patent number: 11013776
    Abstract: A method of treating viral infection, such as viral infection caused by a virus of the Filoviridae family, Flaviviridae family (Flavivirus genus), Deltaretrovirus genus, or Togaviriade family is provided. A composition having at least one cardiac glycoside is used to treat viral infection. The composition can futher include at least one triterpene. Alternatively, the composition comprises at least one, at least two, or at least three triterpenes.
    Type: Grant
    Filed: March 20, 2020
    Date of Patent: May 25, 2021
    Assignee: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Robert A. Newman, Otis C. Addington
  • Method and compositions for treating viral infection
    Patent number: 11007239
    Abstract: A method of treating viral infection, such as viral infection caused by a virus of the Filoviridae family, Flaviviridae family (Flavivirus genus), Deltaretrovirus genus, or Togaviriade family is provided. A composition having at least one cardiac glycoside is used to treat viral infection. The composition can further include at least one triterpene. Alternatively, the composition comprises at least one, at least two, or at least three triterpenes.
    Type: Grant
    Filed: January 21, 2020
    Date of Patent: May 18, 2021
    Assignee: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Robert A. Newman, Otis C. Addington
  • Method and compositions for treating viral infection
    Patent number: 10980852
    Abstract: A method of treating viral infection, such as viral infection caused by a virus of the Filoviridae family, Flaviviridae family (Flavivirus genus), Deltaretrovirus genus, or Togaviriade family is provided. A composition having at least one cardiac glycoside is used to treat viral infection. The composition can further include at least one triterpene. Alternatively, the composition comprises at least one, at least two, or at least three triterpenes.
    Type: Grant
    Filed: March 11, 2020
    Date of Patent: April 20, 2021
    Assignee: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Robert A. Newman, Otis C. Addington
  • Method of and improved composition for treating triterpene-responsive conditions, diseases or disorders
    Patent number: 10973785
    Abstract: A method of treating a triterpene-responsive condition, disease or disorder in a subject by administration of an improved triterpene-based composition is provided. An improved triterpene-based composition comprising at least two or at least three triterpenes present at a molar ratio as described herein is also provided.
    Type: Grant
    Filed: June 8, 2020
    Date of Patent: April 13, 2021
    Assignee: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Robert A. Newman, Otis C. Addington, Donald C. Lo, Linda S. Kaltenbach
  • Method of treating neurological conditions with extract of species or species
    Patent number: 10960037
    Abstract: A method of treating neurological condition in a subject by administration of a neuroprotective composition of a mixture of two or more triterpenes. Alzheimer's disease, Huntington's disease, stroke or Parkinson's disease are treated by administering a therapeutically effective amount of the neuroprotective composition to a subject.
    Type: Grant
    Filed: April 17, 2019
    Date of Patent: March 30, 2021
    Assignee: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Otis C. Addington, Robert A. Newman
  • Method of and Improved Composition for Treating Triterpene-Responsive Conditions, Diseases or Disorders
    Publication number: 20210008017
    Abstract: A method of treating a triterpene-responsive condition, disease or disorder in a subject by administration of an improved triterpene-based composition is provided. An improved triterpene-based composition comprising at least two or at least three triterpenes present at a molar ratio as described herein is also provided.
    Type: Application
    Filed: June 8, 2020
    Publication date: January 14, 2021
    Applicant: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: ROBERT A. NEWMAN, OTIS C. ADDINGTON, DONALD C. LO, LINDA S. KALTENBACH
  • Method and compositions for treating viral infection
    Patent number: 10874704
    Abstract: A method of treating viral infection, such as viral infection caused by a virus of the Filoviridae family, Flaviviridae family (Flavivirus genus), Deltaretrovirus genus, or Togaviriade family is provided. A composition having at least one cardiac glycoside is used to treat viral infection. The composition can futher include at least one triterpene. Alternatively, the composition comprises at least one, at leat two, or at least three triterpenes.
    Type: Grant
    Filed: February 3, 2020
    Date of Patent: December 29, 2020
    Assignee: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Robert A. Newman, Otis C. Addington
  • Method and compostitions for treating coronavirus infection
    Patent number: 10729735
    Abstract: A method of treating viral infection, such as viral infection caused by a virus of the Coronaviridae family, is provided. A composition having at least oleandrin is used to treat viral infection.
    Type: Grant
    Filed: June 8, 2020
    Date of Patent: August 4, 2020
    Assignee: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Robert A. Newman, Otis C. Addington
  • Method of and improved composition for treating triterpene-responsive conditions, diseases or disorders
    Patent number: 10722482
    Abstract: A method of treating a triterpene-responsive condition, disease or disorder in a subject by administration of an improved triterpene-based composition is provided. An improved triterpene-based composition comprising at least two or at least three triterpenes present at a molar ratio as described herein is also provided.
    Type: Grant
    Filed: November 8, 2018
    Date of Patent: July 28, 2020
    Assignee: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Robert A. Newman, Otis C. Addington, Donald C. Lo, Linda S. Kaltenbach